Afroditi Avgerinou

Afroditi is a Real World Data Solutions Lead in Pfizer. She develops capabilities in the RWD space in support of internal users and works closely with Medical Epidemiology, Real World Evidence, HEOR and Digital. Some of her recent work includes solutions around RWD cataloguing, metadata management, profiling, quality, AI analytics and FAIR RWD.  She is an expert of the RWD landscape, commercial vendors and other health data providers and a "translator" bridging technical and business teams. She is involved in developing strategy for RWD and also for the broader data analytics space, with particular focus in oncology. Afroditi is also the Pfizer lead for the IMI Health Outcomes Observatory (H2O) project, a 24-member public-private partnership which has set up a pioneering data ecosystem in Europe, focusing on the collection and sharing of standardized RWD and Patient Reported Outcomes (PROs). Afroditi is active in promoting RWD knowledge, use, innovation, thought leadership and public-private partnerships across her organization. Previously, Afroditi worked for IQVIA where she supported pharma in setting up RWD/RWE studies (incl. data landscaping, feasibility, external comparators, HCRU studies) across multiple disease areas including oncology, endocrinology and rare diseases. She was also involved in Business Development and in the co-ordination of a Real World Forum which brought together pharma industry leaders. Afroditi holds a PhD in Cell and Gene Therapy from University College London and during her time as an academic researcher worked in the fields of gene therapy, cell therapy, rare diseases, regenerative medicine, molecular biology, genomics, bioinformatics and population health science